choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Dimebon

Dimebon Newsletter
  • Dimebon drug may be used in treatment for Huntington disease 09 Aug 2020 00:50 GMT

    … early stage clinical trial of the tentative drug, dimebon (latrepirdine) … appear to be no treatments that may effectually change … and functional results in Alzheimer’s disease. Study authors … pharmaceutical company which funded the study. Apparently, the drug

  • IIT-Hyderabad researchers make headway in potential treatment of ALS 06 Feb 2020 21:49 GMT

    Dimebon. Dimebon is an antihistamine that was studied for treatment … of neurodegenerative disorders by an American pharmaceutical … promising drug for potential treatment of … Department of Biotechnology, IIT Hyderabad …

  • Most Experimental Drugs are Tested Offshore–Raising Concerns about Data 10 Sep 2017 11:36 GMT

    … herpes vaccine trial isn’t all that unusual. Nearly all drug … of clinical trials has brought new treatments to historically … winner when its Alzheimer’s compound, called Dimebon, produced by … Sinai Medical Center in Los Angeles, chaired the FDA advisory …

  • No Effect: Axovant Drug Is Latest Casualty In Alzheimer’s Battle 26 Sep 2017 11:47 GMT

    … an Alzheimer’s treatment has failed. An unusual biotech company … Alzheimer’s development, first touting a drug called dimebondrug to launch a grander plan: Find deep discounts on the pharmaceuticalpill from Lundbeck, idalopirdine, failed two Phase 3 trials

  • Calif. Startup Gambles On Development Of Alzheimer’s Treatment 07 Sep 2017 20:23 GMT

    Alzheimer';s Drug Medivation, a California startup, was developing a treatment for Alzheimer … product. ... The drug, Dimebon, failed all five of the trial’s key metrics … Prescription Drug Prices Intensifies Backers of a measure to require pharmaceutical

Satisfied with the content?

Continue to create your account.